Metagenomic testing as a means of identifying the pathogens causing Kidney disease
Type of Spiritual Experience
A description of the experience
Pediatr Nephrol. 2017 Jun;32(6):921-931. doi: 10.1007/s00467-016-3392-7. Epub 2016 Apr 29.
Gut microbiome and kidney disease: a bidirectional relationship.
Al Khodor S1, Shatat IF2,3,4.
1Infectious Disease Unit, Division of Translational Medicine, Sidra Medical and Research Center, PO Box 26999, Doha, Qatar. firstname.lastname@example.org.
2Pediatric Nephrology and Hypertension, SIDRA Medical and Research Center, Doha, Qatar.
3Medical University of South Carolina, Charleston, SC, USA.
4Weill Cornell Medical College, New York, NY, USA.
Recent technological advances and efforts, including powerful metagenomic and metatranscriptomic analyses, have led to a tremendous growth in our understanding of microbial communities. Changes in microbial abundance or composition of human microbial communities impact human health or disease state. However, explorations into the mechanisms underlying host-microbe interactions in health and disease are still in their infancy. Although changes in the gut microbiota have been described in patients with kidney disease, the relationships between pathogenesis, mechanisms of disease progression, and the gut microbiome are still evolving. Here, we review changes in the host-microbiome symbiotic relationship in an attempt to explore the bidirectional relationship in which alterations in the microbiome affect kidney disease progression and how kidney disease may disrupt a balanced microbiome. We also discuss potential targeted interventions that may help re-establish this symbiosis and propose more effective ways to deploy traditional treatments in patients with kidney disease.
Acute kidney injury; Chronic kidney disease; Dysbiosis; End-stage renal disease; Hemodialysis; Hypertension; Microbiota; Peritoneal dialysis; Prebiotics; Probiotics; Transplantation